【1 月 14 日,礼来公司称计划以最高 25 亿美元现金收购 Scorpion Therapeutics 的实验性癌症疗法来拓展癌症治疗产品线。】公司将收购 Scorpion 的实验性口服疗法 STX-478,其正在进行乳癌和其他晚期实体瘤的早期试验。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.